Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,222 public trials 542 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Recruiting

A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)

NCT06780150

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Uniklinik RWTH Aachen Aachen, Germany
  • Gesundheitszentrum St. Marien GmbH Amberg, Germany
  • Sächsisches Krankenhaus Arnsdorf Arnsdorf, Germany
  • Neuropraxis im Stadtpalais Dres. Ulzheimer/Herröder/Wessig GbR Aschaffenburg, Germany
View all 92 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Alabama Neurology Associates PC Birmingham, Alabama, United States
  • Ctr for Neurology and Spine Phoenix, Arizona, United States
  • AZ Integrated Neuro and Spine Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
View all 236 locations
View Trial Details
Recruiting

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Alabama Neurology Associates- Site Number : 8400019 Homewood, Alabama, United States
  • Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014 Scottsdale, Arizona, United States
  • Keck School of Medicine of University of Southern California- Site Number : 8400002 Los Angeles, California, United States
  • University of California Irvine Medical Center- Site Number : 8400007 Orange, California, United States
View all 129 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

NCT06858579

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Clinical Study Site Birmingham, Alabama, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Scottsdale, Arizona, United States
  • Clinical Study Site Los Angeles, California, United States
View all 180 locations
View Trial Details
Recruiting

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT05199688

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • Children's Hospital Colorado. Denver, Colorado, United States
  • Hospital de Pediatría S.A.M.I.C.- Prof. Dr. Juan P. Garrahan Ciudad Autonoma Buenos Aires, Argentina
  • Clinica Universitaria Reina Fabiola Córdoba, Argentina
  • Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Recruiting

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

NCT06987539

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Austin Neuromuscular Center Austin, Texas, United States
  • Hopital Armand Trousseau Paris, France
  • Hospital Universitari i Politecnic La Fe Valencia, Spain
  • John Radcliffe Hospital Headington, Oxford, United Kingdom
View Trial Details
Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT07540221

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy), +12 more
Locations
  • GC2402 Study Site 104 Rancho Mirage, California, United States
  • GC2402 Study Site 109 Coral Springs, Florida, United States
  • GC2402 Study Site 105 Miami, Florida, United States
  • GC2402 Study Site 103 Port Charlotte, Florida, United States
View Trial Details

Related conditions